FDA approves Abbott’s genetic test for leukemia
Earlier on Monday, Abbott Laboratories announced that a genetic test intended to diagnose chronic lymphocytic leukemia (CLL) patients has been
Read more
Clinical Research Society
International Society for Clinical Research and Translational Medicine